InvestorsHub Logo
Followers 414
Posts 24229
Boards Moderated 1
Alias Born 11/24/2012

Re: None

Thursday, 09/05/2013 10:59:22 PM

Thursday, September 05, 2013 10:59:22 PM

Post# of 1368
NEWS: Press Ventures dba Biosafety Systems Inc., Expands Into European Market With New Corporate Headquarters

09/05/2013 @ 5:04PM

Press Ventures Inc. (OTCQB:PVEN) ("Press Ventures" or the "Company"), is pleased to announce that the Company has established a new European Union (EU) corporate headquarters.

With the recently announced addition of our new CEO, it made strong business sense to have a new corporate focus in the EU where Mr. Denkiewicz's extensive business contacts and vast experience will enhance the Company's efforts to bring its product to the marketplace rapidly. There is strong support within the EU for "natural" biosafety solutions for the food and commercial building sectors. The Company feels that EU business development is a very important opportunity for its patented Cedar Leaf Oil Diffusion ("CLO-D") technology.

"Through our research, we have come to believe that the EU represents an enormous multi-billion dollar market opportunity for our patented cedar oil biosafety system, the Company, and its shareholders," stated Mr. Edward Denkiewicz, CEO of Press Ventures dba BioSafety Solutions Inc. "There is a global movement away from the use of harmful chemicals in our lives and our all-natural biosafety solution has been proven to be 100% safe, while still effectively eradicating dangerous bacteria and viruses from affecting humans. The opening of this new corporate headquarters in Warsaw, Poland is a truly exciting step forward for the Company and will form a base of operations in the center of what we feel will be one of our main global markets."

Traditionally, Europeans have shown a strong resistance to dangerous chemical biosafety solutions that can negatively affect human health. The potential EU market targeted for the Company's patented Cedar Leaf Oil Diffusion ("CLO-D") technology is estimated at over $28 billion to target bacteria and viruses in food processing facilities alone. The Company will also target another potential multi-billion market opportunity in hospital biosafety. Hospitals are constantly fighting the spread of infectious diseases and bacteria on a daily basis. While the Company's CLO-D technology is the premier effective all-natural biosafety solution which has been proven 100% safe and not harmful to humans, there are no assurances that the Company will be successful in developing or exploiting such potential markets.

http://ih.advfn.com/p.php?pid=nmona&article=59097327&symbol=PVEN